AUTH/1973/3/07: General Practitioner v Bayer — SortEDin10 erectile dysfunction disease awareness campaign (No breach)

📅 2007 | 🖉 Dr Anzal Qurbain
📊

Key facts

Case numberAUTH/1973/3/07
PartiesGeneral Practitioner v Bayer
Campaign/materialSortEDin10 erectile dysfunction (ED) disease awareness campaign (ads; later leaflets and website)
Main issueWhether “SortEDin10” implied ED could be “sorted”/resolved in a single 10-minute GP consultation (misleading expectations)
Applicable Code year2006
Clause(s) consideredClause 20.2
Complaint received09 March 2007
Case completed27 April 2007 (HTML page lists completed 26 April 2007)
AppealNo appeal
DecisionNo breach
SanctionsNone stated

Download the full case report (PDF)


Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
🎬 Expert Video Walkthrough
🎬
Video walkthrough — coming for members
Subscribe now and get expert video analysis for every case as we publish them.
Subscribe — from £299/yr
📋

What happened

  • The PMCPA Director noted a Financial Times article (17 Feb) criticising Bayer’s SortEDin10 erectile dysfunction (ED) disease awareness campaign and contacted the author (a general practitioner).
  • The GP then submitted a complaint alleging the ads encouraged men to think ED could be “sorted” in 10 minutes.
  • The complaint argued a typical 10-minute GP appointment would not cover the necessary assessment (physical exam, psychological issues, possible blood tests, follow-up), and that the messaging created unrealistic expectations for patients and doctors.
  • The Authority asked Bayer to respond in relation to Clause 20.2 (2006 Code).
  • Bayer said SortEDin10 was intended to encourage embarrassed patients to take the first step and see their GP; “10 minutes” reflected an average planned GP consultation and was not intended to mislead or raise unfounded hopes.
  • Bayer stated that for many men the first consultation could be productive, noting that a substantial proportion might receive treatment (including PDE5 inhibitors) at the first visit where appropriate.
⚖️

Outcome

  • No breach of the Code was ruled.
  • No breach of Clause 20.2: the Panel did not consider the public would believe ED would be completely resolved after one 10-minute consultation.
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training